FDA Approves Velsipity for Moderate-to-Severe Ulcerative Colitis in Adults

TUESDAY, Oct. 17, 2023 -- The U.S. Food and Drug Administration approved Velsipity (etrasimod) for adults with moderately to severely active ulcerative colitis (UC). The approval was based on results from the ELEVATE UC phase 3 registrational...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news